Raymond George Hill SEC Filing Summary

On September 2, 2026, Raymond George Hill, a director at Addex Therapeutics Ltd., reported transactions involving the exercise of stock options and the acquisition of common stock. These transactions, exempt under Rule 16b-6(d) and Rule 16b-3, involved the exercise of 273,107 stock options, with the strike price being repriced to $0.032. Following this, 1,365,532 shares of common stock were acquired. Of these, 797,563 shares were acquired under a deferred strike price payment plan with an initial strike price of $0.16, and 567,969 shares were acquired with an initial strike price of $0.053. The strike prices were converted from CHF to USD at a rate of $1.2296 per CHF 1.00. Post-transaction, Hill holds 1,365,532 shares of common stock.